Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 16 February 2007:
Vol. 315. no. 5814, p. 924
DOI: 10.1126/science.315.5814.924
Prev | Table of Contents | Next

News of the Week

DIAGNOSTICS:
Amid Debate, Gene-Based Cancer Test Approved

Jennifer Couzin

Last week, the U.S. Food and Drug Administration issued its first-ever approval of a multigene prognostic test and 2 days later held a contentious meeting to discuss more stringent oversight of this area. (Read more.)

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non-Small-Cell Lung Cancer.
P. Roepman, J. Jassem, E. F. Smit, T. Muley, J. Niklinski, T. van de Velde, A. T. Witteveen, W. Rzyman, A. Floore, S. Burgers, et al. (2009)
Clin. Cancer Res. 15, 284-290
   Abstract »    Full Text »    PDF »
Clinical Application of the 70-Gene Profile: The MINDACT Trial.
F. Cardoso, L. Van't Veer, E. Rutgers, S. Loi, S. Mook, and M. J. Piccart-Gebhart (2008)
J. Clin. Oncol. 26, 729-735
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)